Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
Sung YK, Cho SK, Kim D, Won S, Choi CB, Bang SY, Hong SJ, Kim HA, Koh EM, Lee HS, Suh CH, Yoo DH, Bae SC.
Sung YK, et al. Among authors: kim d, kim ha.
Rheumatol Int. 2017 Jun;37(6):1007-1014. doi: 10.1007/s00296-017-3663-z. Epub 2017 Feb 18.
Rheumatol Int. 2017.
PMID: 28214924